Grasim margin expands as post-results stock move dwarfs its history
Revenue growth outpaced expenses in Q4FY26, while a lower tax rate and higher other income also supported sequential profit growth.
Filed 20 May 2026, 15:39 IST · after market close · Grasim Industries Ltd (GRASIM)
Key takeaways
- Consolidated operating margin rose 1.80 percentage points sequentially to 15.23% as revenue grew faster than expenses.
- Consolidated net profit increased 27.88% year on year, while other income contributed 5.10% of profit before tax.
- The stock gained 6.17% on the first trading day after results, far above its 0.74% median absolute move after the past eight results.
Price around the results
Revenue momentum lifted consolidated operating profit
Consolidated revenue grew 15.32% sequentially and 15.44% year on year, with operating profit rising faster at 30.82% and 26.26%, respectively. Expenses increased 12.92% sequentially and 13.69% year on year, so the wider revenue-cost spread lifted operating margin by 1.80 percentage points sequentially and 1.30 percentage points year on year. Net profit growth was slower than operating profit growth year on year because interest expense rose 12.26%.
Margin recovery continued, but other income aided profit
Operating margin improved from 12.21% in Q2FY26 to 13.43% in Q3FY26 and 15.23% in Q4FY26, marking a second consecutive quarterly expansion. Other income was 5.10% of profit before tax in Q4FY26, so it supported reported profit but was not the main operating driver; it was also down 46.52% year on year. The sequential tax-rate decline of 1.67 percentage points and 1.12% fall in interest expense further supported net profit.
Grasim remained below the reported commodities peer median
Grasim's consolidated operating margin of 15.23% was 3.54 percentage points below the 18.77% median for the 51 commodities peers that had reported the same quarter. The margin trend nonetheless moved higher across the latest two quarters, after falling to 12.21% in Q2FY26 from 15.17% in Q1FY26.
Management outlined Lyocell and chemicals projects
Management said Phase 1 of the Lyocell expansion, with 55 KTPA of capacity within a proposed 110 KTPA project, is targeted for commissioning by mid-2027. The company said chlorine integration is expected to reach approximately 70% after ongoing projects are commissioned and ramped up, while the chemicals business is focusing on cost competitiveness through a higher share of renewable power. The presentation reported FY26 planned capex of Rs 2,263 cr, of which Rs 1,980 cr was spent, and said the second Birla Opus price-increase phase was under implementation in Q1FY27.
The market reaction was unusual for Grasim
The stock rose 6.17% on the first trading day after the results and remained up 5.09% after five sessions, with first-day volume at 4.58 times its reference level. That reaction was much larger than the 0.74% median absolute move across the past eight result reactions, which were evenly split between four rises and four falls.
Q4FY26 at a glance
Consolidated figures as filed with NSE — cross-checked against an independent source.
| Line item | Q4FY26 | Q3FY26 | QoQ | YoY |
|---|---|---|---|---|
| Revenue | ₹51,101 cr | ₹44,312 cr | +15.32% | +15.44% |
| Other income | ₹259 cr | ₹9 cr | +2808.19% | -46.52% |
| Expenses | ₹43,318 cr | ₹38,363 cr | +12.92% | +13.69% |
| Operating profit | ₹7,783 cr | ₹5,949 cr | +30.82% | +26.26% |
| Operating margin (%) | 15.23% | 13.43% | — | — |
| Interest | ₹922 cr | ₹933 cr | -1.12% | +12.26% |
| Depreciation | ₹2,042 cr | ₹1,975 cr | +3.38% | +11.49% |
| Profit before tax | ₹5,078 cr | ₹3,051 cr | +66.47% | +27.09% |
| Tax | ₹1,276 cr | ₹818 cr | +56.07% | +24.78% |
| Net profit | ₹3,802 cr | ₹2,233 cr | +70.28% | +27.88% |
| EPS (₹) | ₹28.87 | ₹15.28 | +88.94% | +29.93% |
Operating margin of 15.23% compares with a Commodities sector median of 18.77% across 51 peers that have reported Q4FY26.
How the stock reacted
| Window | Stock | vs NIFTY |
|---|---|---|
| Results day | +6.17% | +6.19% |
| Next session | +6.20% | — |
| 5 sessions | +5.09% | +5.56% |
| 15 sessions | +4.52% | — |
| 30 sessions | +8.14% | — |
Volume on the results session was 4.58× its 20-day average.
What management said
From the company’s own investor presentation. Each point is checked against the source document before it appears here.
Guidance & outlook
- Phase 1 of the Lyocell capacity expansion is targeted for commissioning by mid-2027.
- Chlorine integration is expected to reach approximately 70% after ongoing projects are commissioned and ramped up.
Planned next quarter
- Birla Opus’s second price-increase phase is under implementation in Q1FY27.
Expansion
- The company is developing 55 KTPA of Phase 1 Lyocell capacity within a proposed 110 KTPA project.
- FY26 planned capex was ₹2,263 crore, with ₹1,980 crore spent, according to the standalone capex plan.
- FY26 planned capex for Birla Opus was ₹643 crore, with ₹550 crore spent.
New initiatives
- The chemicals business is focusing on cost competitiveness by increasing its share of renewable power.
What to watch
- Whether consolidated operating margin holds above 15.23% after its two-quarter recovery.
- Whether other income remains near or below its 5.10% share of profit before tax.
- Progress against management's targeted mid-2027 commissioning of the 55 KTPA Lyocell Phase 1 capacity.